Lianhua Qingwen exerts anti-liver cancer effects and synergistic efficacy with sorafenib through PI3K/AKT pathway: Integrating network pharmacology, molecular docking, and experimental validation
- Resource Type
- Article
- Source
- In
Gene 20 June 2024 912 - Subject
- Language
- ISSN
- 0378-1119